InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-17.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Durso Jerome Benedict, Chief Executive Officer. Insider active across 2 companies, notably Intercept Pharmaceuticals, INC.. Aggregated, 11 filings have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €184k. History available since 1 July 2021. The latest transaction was disclosed on 13 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Durso Jerome Benedict
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
15,000 shares@ US$2.950.0075% mcap20.8% of flowCommon Stock, par value $0.0001SEC:0001698665-26-000007:0
Canonical exit: 11 Nov 2026 (T+90)
15,000 shares@ US$3.14100.0% of flowCommon Stock, par value $0.0001SEC:0001698665-26-000005:0
Canonical exit: 30 Jun 2026 (T+90)
20,000 shares@ US$3.539541.9% of flowCommon Stock, par value $0.0001SEC:0001698665-26-000003:0
Canonical exit: 4 Jun 2026 (T+90)
12,500 shares@ US$4.125552.0% of flowCommon Stock, par value $0.0001SEC:0001698665-25-000005:0
Canonical exit: 22 Mar 2026 (T+90)
51,815 shares@ US$19.0077.9% of flowCommon StockSEC:0001104659-23-117096:0
50,400 shares0Common StockSEC:0001104659-23-008582:0
7,083 shares@ US$12.377.0% of flowCommon StockSEC:0001104659-23-000329:0
35,700 shares0Common StockSEC:0001104659-22-009555:0
5,607 shares@ US$16.297.4% of flowCommon StockSEC:0001104659-22-000917:0
289 shares@ US$15.220.3% of flowCommon StockSEC:0001104659-21-123209:0
289 shares@ US$20.470.5% of flowCommon StockSEC:0001104659-21-089031:0
11 of 11 declarations
About Durso Jerome Benedict
Durso Jerome Benedict is Directeur Général. He has 10 filings in total, and across the 10 recent filings held, the transactions cover the period from 2021-07-02 to 2026-04-01, with EUR 145665 of buys and EUR 0 of sells. The companies cited in these filings are Intercept Pharmaceuticals, INC. and Altimmune, Inc., and the modal transaction nature is Tax withholding.
